InMed Pharmaceuticals Inc. Common Shares

INMNASDAQ • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
1.51 USD
↘ 0.04 (2.58%)AT CLOSE (11:59 AM EDT)
1.52
↗ 0.01 (0.33%)
POST MARKET (AS OF 06:32 PM EDT)
Post Market
AS OF 06:32 PM EDT
1.52
↗ 0.01 (0.33%)
🔴Market: CLOSED

InMed Pharmaceuticals Inc. Common Shares (INM) is currently trading at $1.53. INM shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Strong Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jun 25, 2026.

Open?$1.54
High?$1.57
Low?$1.50
Prev. Close?$1.55
Volume?14.0K
Avg. Volume?3.4M
VWAP?$1.53
Rel. Volume?0.00x
Bid / Ask
Bid?$1.31 × 100
Ask?$1.78 × 100
Spread?$0.47
Midpoint?$1.55
Valuation & Ratios
Market Cap?5.1M
Shares Out?3.3M
Float?2.6M
Float %?89.2%
P/E Ratio?N/A
P/B Ratio?0.75
EPS?-$2.57
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
Themes
Biotech - Drug Development›Rare Disease TherapeuticsCannabis›CBD & Hemp Products
Employees
13
Market Cap
5.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.inmedpharma.com
Listed
2020-11-10
Address
1445-885 WEST GEORGIA ST.
VANCOUVER, A1 V6C 3E8
Phone: (604) 669-7207
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
7
Short Sent.?
51
Piotroski F-Score?0/9Weak
Altman Z-Score?-19.65Distress
Confidence?50%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?5.50%Elevated
Short Interest?143.1K
Days to Cover?1.5
Free Float2.6M
Avg Daily Volume97.7K
Settlement Date2026-06-15
Financial Health
Current Ratio?4.92Strong
Quick Ratio?4.92Strong
Cash Ratio?3.68Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.75CHEAP▾
P/S?
Peers
100
S&P
77
1.58CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
0.0CHEAP▾
EV/Sales?
S&P
97
-0.01CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-123.5%WEAK▾
ROA?
S&P
3
-93.2%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$-22134
Fundamentals ratios updated end of day
MarketsMoversWatchlist